Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT as add-on therapy in mild-to-moderate ulcerative colitis
NCT05538026Completed
- Start
- Sep 2020
- Primary completion
- Jan 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of Fecal Microbiota Transplantation Capsule in ulcerative colitis (UC). Primary endpoint: partial Mayo at 8 weeks. Started Sep 2020; status: completed.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05538026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05538026.